OCUGEN, INC. Financing Cash Flow
OCUGEN, INC. (OCGN) reported Financing Cash Flow of $115.35 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-06
- OCUGEN, INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $80.37M, a 131650.82% increase year-over-year.
- OCUGEN, INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $34.98M.
- OCUGEN, INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $2.00K, a 99.99% decline year-over-year.
- OCUGEN, INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $18.51M, a 46.79% decline year-over-year.
- OCUGEN, INC. net cash provided by (used in) financing activities for fiscal 2025 was $17.33M, a 73.28% decline from fiscal 2024.
- OCUGEN, INC. net cash provided by (used in) financing activities for fiscal 2024 was $64.86M, a 210.61% increase from fiscal 2023.
- OCUGEN, INC. net cash provided by (used in) financing activities for fiscal 2023 was $20.88M, a 64.89% decline from fiscal 2022.
- OCUGEN, INC. net cash provided by (used in) financing activities for fiscal 2022 was $59.48M, a 50.72% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 3 month as first filed | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $80.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $115.35M 10-Q · filed 2026-08-06 | $115.35M derived: sum of 3 quarters · filed 2026-08-06 | $133.86M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $34.98M 10-Q · filed 2026-05-08 | $34.99M derived: sum of 2 quarters · filed 2026-05-08 | $53.50M derived: sum of 3 quarters · filed 2026-05-08 | $53.56M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $18.51M derived: sum of 2 quarters · filed 2026-03-04 | $18.57M derived: sum of 3 quarters · filed 2026-08-06 | $17.33M 10-K · filed 2026-03-04 | ||||
| 2025-09-30 | $18.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $18.57M derived: sum of 2 quarters · filed 2026-08-06 | $17.33M 10-Q · filed 2025-11-05 | $47.50M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $61.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$1.18M 10-Q · filed 2026-08-06 | $28.99M derived: sum of 3 quarters · filed 2026-08-06 | $63.77M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | -$1.25M 10-Q · filed 2026-05-08 | $28.93M derived: sum of 2 quarters · filed 2026-05-08 | $63.71M derived: sum of 3 quarters · filed 2026-05-08 | $63.76M derived: sum of 4 quarters · filed 2026-05-08 | ||||
| 2024-12-31 | $30.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $64.96M derived: sum of 2 quarters · filed 2026-03-04 | $65.00M derived: sum of 3 quarters · filed 2026-03-04 | $64.86M 10-K · filed 2026-03-04 | ||||
| 2024-09-30 | $34.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $34.83M derived: sum of 2 quarters · filed 2025-11-05 | $34.69M 10-Q · filed 2025-11-05 | $34.70M derived: sum of 4 quarters · filed 2025-11-05 | ||||
| 2024-06-30 | $45.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | -$100.00K 10-Q · filed 2025-08-04 | -$84.00K derived: sum of 3 quarters · filed 2025-08-04 | -$119.00K derived: sum of 4 quarters · filed 2025-08-04 | ||||
| 2024-03-31 | -$145.00K 10-Q · filed 2025-05-09 | -$129.00K derived: sum of 2 quarters · filed 2025-05-09 | -$164.00K derived: sum of 3 quarters · filed 2025-05-09 | $15.24M derived: sum of 4 quarters · filed 2025-05-09 | ||||
| 2023-12-31 | $16.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | -$19.00K derived: sum of 2 quarters · filed 2025-03-05 | $15.38M derived: sum of 3 quarters · filed 2025-03-05 | $20.88M 10-K · filed 2025-03-05 | ||||
| 2023-09-30 | -$35.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $15.37M derived: sum of 2 quarters · filed 2024-11-14 | $20.86M 10-Q · filed 2024-11-14 | $29.04M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $15.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $20.90M 10-Q · filed 2024-08-08 | $29.07M derived: sum of 3 quarters · filed 2024-08-08 | $30.04M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | $5.50M 10-Q · filed 2024-05-14 | $13.67M derived: sum of 2 quarters · filed 2024-05-14 | $14.63M derived: sum of 3 quarters · filed 2024-05-14 | $14.87M derived: sum of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | $8.18M derived: 10-K 12 month − 10-K 9 month · filed 2024-04-16 | $9.14M derived: sum of 2 quarters · filed 2024-04-16 | $9.37M derived: sum of 3 quarters · filed 2024-04-16 | $59.48M 10-K · filed 2024-04-16 | ||||
| 2022-09-30 | $962.00K derived: 10-K 9 month − 10-K 6 month · filed 2024-04-16 | $1.20M derived: sum of 2 quarters · filed 2024-04-16 | $51.30M 10-K · filed 2024-04-16 | $51.91M derived: sum of 4 quarters · filed 2024-04-16 | ||||
| 2022-06-30 | $236.00K derived: 10-K 6 month − 10-K 3 month · filed 2024-04-16 | $50.34M 10-K · filed 2024-04-16 | $50.94M derived: sum of 3 quarters · filed 2024-04-16 | $51.05M derived: sum of 4 quarters · filed 2024-04-16 | ||||
| 2022-03-31 | $50.10M 10-K · filed 2024-04-16 | $50.71M derived: sum of 2 quarters · filed 2024-04-16 | $50.82M derived: sum of 3 quarters · filed 2024-04-16 | $144.48M derived: sum of 4 quarters · filed 2024-04-16 | ||||
| 2021-12-31 | $605.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $715.00K derived: sum of 2 quarters · filed 2023-02-28 | $94.38M derived: sum of 3 quarters · filed 2023-02-28 | $120.68M 10-K · filed 2023-02-28 | ||||
| 2021-09-30 | $110.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $93.77M derived: sum of 2 quarters · filed 2022-11-08 | $120.07M 10-Q · filed 2022-11-08 | $129.54M derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-06-30 | $93.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $119.96M 10-Q · filed 2022-08-05 | $129.43M derived: sum of 3 quarters · filed 2022-08-05 | $136.24M derived: sum of 4 quarters · filed 2022-08-05 | ||||
| 2021-03-31 | $26.30M 10-Q · filed 2022-05-06 | $35.76M derived: sum of 2 quarters · filed 2022-05-06 | $42.58M derived: sum of 3 quarters · filed 2022-05-06 | $57.42M derived: sum of 4 quarters · filed 2022-05-06 | ||||
| 2020-12-31 | $9.47M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $16.28M derived: sum of 2 quarters · filed 2022-02-28 | $31.12M derived: sum of 3 quarters · filed 2022-02-28 | $31.61M 10-K · filed 2022-02-28 | $31.61M 10-K · filed 2021-03-19 | |||
| 2020-09-30 | $6.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $21.66M derived: sum of 2 quarters · filed 2021-11-09 | $22.14M 10-Q · filed 2021-11-09 | $22.14M 10-Q · filed 2020-11-06 | $23.05M derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2020-06-30 | $14.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $15.33M 10-Q · filed 2021-08-06 | $15.33M 10-Q · filed 2020-08-14 | $16.24M derived: sum of 3 quarters · filed 2022-02-28 | $35.18M derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2020-03-31 | $488.00K 10-Q · filed 2021-05-07 | $488.30K 10-Q · filed 2020-05-08 | $1.40M derived: sum of 2 quarters · filed 2022-02-28 | $20.34M derived: sum of 3 quarters · filed 2022-02-28 | $24.20M derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2019-12-31 | $907.13K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $19.85M derived: sum of 2 quarters · filed 2022-02-28 | $23.71M derived: sum of 3 quarters · filed 2022-02-28 | $25.07M 10-K · filed 2022-02-28 | $25.07M 10-K · filed 2020-03-27 | |||
| 2019-09-30 | $18.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $22.80M derived: sum of 2 quarters · filed 2020-11-06 | $24.16M 10-Q · filed 2020-11-06 | $26.09M derived: sum of 4 quarters · filed 2020-11-06 | ||||
| 2019-06-30 | $3.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $5.21M 10-Q · filed 2020-08-14 | -$1.45M 10-Q · filed 2019-08-09 | $7.14M derived: sum of 3 quarters · filed 2020-08-14 | $6.44M derived: sum of 4 quarters · filed 2020-08-14 | |||
| 2019-03-31 | $1.36M 10-Q · filed 2020-05-08 | $326.00K 10-Q · filed 2019-05-15 | $3.29M derived: sum of 2 quarters · filed 2020-05-08 | $2.58M derived: sum of 3 quarters · filed 2020-05-08 | $3.05M derived: sum of 4 quarters · filed 2020-05-08 | |||
| 2018-12-31 | $1.93M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $1.22M derived: sum of 2 quarters · filed 2020-03-27 | $1.69M derived: sum of 3 quarters · filed 2020-03-27 | $7.18M 10-K · filed 2020-03-27 | $25.35M 10-K · filed 2019-03-22 | |||
| 2018-09-30 | -$706.99K derived: 10-Q 9 month − 8-K/A 6 month · filed 2019-11-12 | -$240.96K derived: sum of 2 quarters · filed 2019-11-12 | $5.25M 10-Q · filed 2019-11-12 | $7.99M 10-Q · filed 2018-11-08 | $5.11M derived: sum of 4 quarters · filed 2019-11-12 | |||
| 2018-06-30 | $466.03K derived: 8-K/A 6 month − 10-Q 3 month · filed 2019-10-07 | $5.96M 8-K/A · filed 2019-10-07 | $5.45M 10-Q · filed 2018-08-09 | $5.82M derived: sum of 3 quarters · filed 2019-10-07 | $5.68M derived: sum of 4 quarters · filed 2019-10-07 | |||
| 2018-03-31 | $5.50M 10-Q · filed 2019-05-15 | $5.35M derived: sum of 2 quarters · filed 2019-05-15 | $5.21M derived: sum of 3 quarters · filed 2019-05-15 | |||||
| 2017-12-31 | -$145.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | -$286.00K derived: sum of 2 quarters · filed 2019-03-22 | -$577.00K 10-K · filed 2019-03-22 | |||||
| 2017-09-30 | -$141.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$432.00K 10-Q · filed 2018-11-08 | ||||||
| 2017-06-30 | -$291.00K 10-Q · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |